Phase II study of preoperative bevacizumab in combination with capecitabine and radiotherapy in patients with locally advanced resectable colorectal cancer.
Phase of Trial: Phase II
Latest Information Update: 31 Aug 2017
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- Acronyms XEBERECTO
- 21 Feb 2015 Status changed from active, no longer recruiting to completed as per European Clinical Trials Database record.
- 02 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Feb 2009 New trial record